Trial intelligence / Profile preview

Odontocide versus calcium hydroxide paste for interappointment pain in endodontic treatment

ACTRN12612000630819Phase 3Not yet recruiting

Sponsor
University of Melbourne
Start
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in apical periodontitis (AP) and pulpitis comparing Odontocide arm with Calcium hydroxide control arm (2 arms). Primary endpoint: Interappointment pain. Planned start Jul 2012; status: not yet recruiting.

02

Drugs

odontocidecalcium hydroxide
03

Conditions

apical periodontitis (AP)pulpitis

Beyond the preview

Go deeper on ACTRN12612000630819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612000630819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call